These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33530318)

  • 1. Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis.
    Sigalla J; Duparc Alegria N; Le Roux E; Toumazi A; Thiollier AF; Holvoet L; Benkerrou M; Dugue S; Koehl B
    Children (Basel); 2021 Jan; 8(2):. PubMed ID: 33530318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
    Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
    Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
    Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
    J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study.
    Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
    J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
    Shah NR; Bhor M; Latremouille-Viau D; Kumar Sharma V; Puckrein GA; Gagnon-Sanschagrin P; Khare A; Kumar Singh M; Serra E; Davidson M; Xu L; Guerin A
    J Med Econ; 2020 Nov; 23(11):1345-1355. PubMed ID: 32815766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
    Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hospitalization for vaso-occlusive crisis on health-related quality of life in children with sickle cell disease.
    Vuong C; Moussa I; van Muilekom MM; Heijboer H; Rettenbacher E; Haverman L; Twisk J; Fijnvandraat K; Eckhardt CL
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30691. PubMed ID: 37749772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
    Kenney MO; Becerra B; Mallikarjunan A; Shah N; Smith WR
    Pain Med; 2022 Dec; 23(12):2042-2049. PubMed ID: 35708641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
    Han J; Saraf SL; Gordeuk VR
    Pharmacotherapy; 2020 Jun; 40(6):535-543. PubMed ID: 32350885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review.
    Akindele AO; Jalkh AP; Eastmond AK; Shetty C; Rizvi SMHA; Sharaf J; Williams KD; Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan SN; Chavarria YY; Balani P
    Cureus; 2022 Aug; 14(8):e28337. PubMed ID: 36176876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
    Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional anesthesia and analgesia in sickle cell pain episodes: A scoping review.
    Howie BA; Rajput K; Chow R
    Interv Pain Med; 2022 Sep; 1(3):100108. PubMed ID: 39238512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Burden of Sickle Cell Disease on Children and Their Caregivers: Caregiver Reports of Children's Health-Related Quality of Life and School Experiences, Caregiver Burden, and Their Association with Frequency of Vaso-Occlusive Crises.
    Campbell A; Rizio AA; McCausland KL; Iorga S; Yen GP; Paulose J; Lee S
    Patient Relat Outcome Meas; 2023; 14():369-381. PubMed ID: 38046665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.
    Zakaria O; Buhalim RA; Almulhim F; Al Jabr FA; Alrashid A; Almutairi M
    Cureus; 2021 May; 13(5):e14980. PubMed ID: 34123674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
    Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
    Adv Ther; 2023 Aug; 40(8):3543-3558. PubMed ID: 37332020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.